{"id":"https://openalex.org/W2979735618","doi":"https://doi.org/10.1128/aac.01387-19","title":"Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Candida Species","display_name":"Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Candida Species","alternate_titles":[],"publication_year":2019,"publication_date":"2019-10-10","ids":{"openalex":"https://openalex.org/W2979735618","doi":"https://doi.org/10.1128/aac.01387-19","mag":"2979735618","pmid":"https://pubmed.ncbi.nlm.nih.gov/31611349","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7187586"},"language":"en","primary_location":{"id":"doi:10.1128/aac.01387-19","doi":"https://doi.org/10.1128/aac.01387-19","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.01387-19","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2979735618"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1128/aac.01387-19","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068879729","display_name":"Mili Kapoor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108517","display_name":"Amplyx Pharmaceuticals (United States)","ror":"https://ror.org/02jfsdq79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mili Kapoor","raw_affiliation_strings":["Amplyx Pharmaceuticals, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amplyx Pharmaceuticals, San Diego, California, USA","institution_ids":["https://openalex.org/I4210108517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014506220","display_name":"Molly K. Moloney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108517","display_name":"Amplyx Pharmaceuticals (United States)","ror":"https://ror.org/02jfsdq79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Molly Moloney","raw_affiliation_strings":["Amplyx Pharmaceuticals, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amplyx Pharmaceuticals, San Diego, California, USA","institution_ids":["https://openalex.org/I4210108517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087949227","display_name":"Quinlyn A. Soltow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108517","display_name":"Amplyx Pharmaceuticals (United States)","ror":"https://ror.org/02jfsdq79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Quinlyn A. Soltow","raw_affiliation_strings":["Amplyx Pharmaceuticals, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amplyx Pharmaceuticals, San Diego, California, USA","institution_ids":["https://openalex.org/I4210108517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110265679","display_name":"Chris M. Pillar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chris M. Pillar","raw_affiliation_strings":["Micromyx, Kalamazoo, Michigan, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Micromyx, Kalamazoo, Michigan, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086601088","display_name":"Karen Joy Shaw","orcid":"https://orcid.org/0000-0003-3060-1328","observed_orcids":["https://orcid.org/0000-0003-3060-1328"]},"institutions":[{"id":"https://openalex.org/I4210108517","display_name":"Amplyx Pharmaceuticals (United States)","ror":"https://ror.org/02jfsdq79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108517"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Karen Joy Shaw","raw_affiliation_strings":["Amplyx Pharmaceuticals, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amplyx Pharmaceuticals, San Diego, California, USA","institution_ids":["https://openalex.org/I4210108517"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5086601088"],"corresponding_institution_ids":["https://openalex.org/I4210108517"],"apc_list":null,"apc_paid":null,"fwci":3.6433,"has_fulltext":true,"cited_by_count":68,"citation_normalized_percentile":{"value":0.93324184,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"64","issue":"1","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11900","display_name":"Fungal Plant Pathogen Control","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1110","display_name":"Plant Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10497","display_name":"Fungal and yeast genetics research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/manogepix","display_name":"manogepix","score":0.949999988079071},{"id":"https://openalex.org/keywords/candida","display_name":"Candida","score":0.8009999990463257},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.531000018119812},{"id":"https://openalex.org/keywords/antifungal-susceptibility","display_name":"antifungal susceptibility","score":0.6489999890327454},{"id":"https://openalex.org/keywords/cross-resistance","display_name":"cross-resistance","score":0.9290000200271606},{"id":"https://openalex.org/keywords/fluconazole","display_name":"fluconazole","score":0.8199999928474426},{"id":"https://openalex.org/keywords/amphotericin-b","display_name":"amphotericin B","score":0.9259999990463257},{"id":"https://openalex.org/keywords/caspofungin","display_name":"caspofungin","score":0.9980000257492065}],"concepts":[{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.6868616938591003},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.6293662786483765},{"id":"https://openalex.org/C193557335","wikidata":"https://www.wikidata.org/wiki/Q61424","display_name":"Acylation","level":3,"score":0.5557738542556763},{"id":"https://openalex.org/C553450214","wikidata":"https://www.wikidata.org/wiki/Q851162","display_name":"Biosynthesis","level":3,"score":0.5470382571220398},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.5223537683486938},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5177035331726074},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3165431618690491},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000217","descriptor_name":"Acyltransferases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000217","descriptor_name":"Acyltransferases","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002175","descriptor_name":"Candida","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002175","descriptor_name":"Candida","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002175","descriptor_name":"Candida","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002177","descriptor_name":"Candidiasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002177","descriptor_name":"Candidiasis","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D005656","descriptor_name":"Fungal Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D005656","descriptor_name":"Fungal Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D005656","descriptor_name":"Fungal Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005800","descriptor_name":"Genes, Fungal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013045","descriptor_name":"Species Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017261","descriptor_name":"Glycosylphosphatidylinositols","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D017261","descriptor_name":"Glycosylphosphatidylinositols","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D017261","descriptor_name":"Glycosylphosphatidylinositols","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D017386","descriptor_name":"Sequence Homology, Amino Acid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D025141","descriptor_name":"Drug Resistance, Fungal","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D029701","descriptor_name":"Saccharomyces cerevisiae Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D029701","descriptor_name":"Saccharomyces cerevisiae Proteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D053898","descriptor_name":"Biosynthetic Pathways","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D053898","descriptor_name":"Biosynthetic Pathways","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1128/aac.01387-19","doi":"https://doi.org/10.1128/aac.01387-19","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.01387-19","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7187586","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7187586/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7187586/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:31611349","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31611349","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1128/aac.01387-19","doi":"https://doi.org/10.1128/aac.01387-19","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.01387-19","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.5683000087738037}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6843081752","display_name":"Developing a novel antifungal targeting Gwt1 for the treatment of invasive aspergillosis and rare mold infections","funder_award_id":"R44AI131864","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320317395","display_name":"Amplyx","ror":"https://ror.org/02jfsdq79"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2979735618.pdf","grobid_xml":"https://content.openalex.org/works/W2979735618.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W615254675","https://openalex.org/W1902677919","https://openalex.org/W1915738035","https://openalex.org/W1965012698","https://openalex.org/W1987354838","https://openalex.org/W1988419689","https://openalex.org/W1988433614","https://openalex.org/W1990892595","https://openalex.org/W2014616328","https://openalex.org/W2020769754","https://openalex.org/W2021339453","https://openalex.org/W2046012592","https://openalex.org/W2065326954","https://openalex.org/W2075016274","https://openalex.org/W2107712108","https://openalex.org/W2107794472","https://openalex.org/W2110436000","https://openalex.org/W2114599108","https://openalex.org/W2117472236","https://openalex.org/W2121543056","https://openalex.org/W2127322768","https://openalex.org/W2136677555","https://openalex.org/W2184546388","https://openalex.org/W2504243452","https://openalex.org/W2667665685","https://openalex.org/W2746687770","https://openalex.org/W2754274550","https://openalex.org/W2767031614","https://openalex.org/W2805470919","https://openalex.org/W2884671633","https://openalex.org/W2885297341","https://openalex.org/W2887248591","https://openalex.org/W2911592729","https://openalex.org/W3103198478","https://openalex.org/W4239089151"],"related_works":["https://openalex.org/W7214300880","https://openalex.org/W7204957797","https://openalex.org/W3080618403","https://openalex.org/W3118881330","https://openalex.org/W2963241446","https://openalex.org/W3111467822","https://openalex.org/W4412596199","https://openalex.org/W2783397783","https://openalex.org/W3118716959"],"abstract_inverted_index":{"Gwt1,":[0],"respectively,":[1],"all":[2],"demonstrated":[3,75],"reduced":[4],"susceptibility":[5,38],"to":[6,18,25,39],"MGX":[7,19,74],"versus":[8],"control":[9],"strains,":[10],"suggesting":[11],"the":[12,26,57,69],"importance":[13],"of":[14,30,59],"this":[15],"valine":[16],"residue":[17],"binding":[20],"across":[21],"different":[22],"species.":[23],"Cross-resistance":[24],"three":[27],"major":[28],"classes":[29],"antifungals":[31],"was":[32,51,72],"evaluated,":[33],"but":[34],"no":[35],"changes":[36],"in":[37,46,53,68,91],"amphotericin":[40],"B":[41],"or":[42],"caspofungin":[43],"were":[44],"observed":[45,52],"any":[47],"mutant.":[48],"No":[49],"change":[50],"fluconazole":[54,70],"susceptibility,":[55],"with":[56,84],"exception":[58],"a":[60,65,76],"single":[61],"non-Gwt1":[62],"mutant,":[63],"where":[64],"4-fold":[66],"increase":[67],"MIC":[71],"observed.":[73],"relatively":[77],"low":[78],"potential":[79],"for":[80],"resistance":[81],"development,":[82],"consistent":[83],"other":[85],"approved":[86],"antifungal":[87],"agents":[88],"and":[89],"those":[90],"clinical":[92],"development.":[93]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2979735618","counts_by_year":[{"year":2026,"cited_by_count":16},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":8}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2019-10-18T00:00:00"}
